拢30m funding for disease diagnosis firm Perspectum
Perspectum, a precision health company which develops medical imaging tools to improve the diagnosis of metabolic diseases and cancer, has raised 拢30 million Series C funding. Led by Oppenheimer Holdings, it brings the total amount raised since the Oxford company鈥檚 inception to $120m. Since the beginning of 2021, 77 million US adults covered by Medicare … Continue reading 拢30m funding for disease diagnosis firm Perspectum
